The European Commission's Heart Health Conference aims to promote cardiovascular disease (CVD) prevention measures across Europe. The conference concluded with key actions for member states and the EC to implement to improve cardiovascular health in Europe, emphasizing the need for a long-term approach through public health strategies.
A Dutch study found that non-cardiac drugs affecting heart electrical activity increase sudden cardiac death risk by three times. Anti-psychotics and GI medications were most closely linked to this increased risk.
A large European study found that only 60% of patients with heart failure were treated according to the ESC guidelines for the five most commonly used cardiac drugs. Adherence to treatment guidelines was independently correlated with patient outcomes, including hospitalization rates and time to readmission.
A new study published in the Journal of the American College of Cardiology shows that drug eluting stents are just as effective and safe for women as they are for men. However, female patients experience higher re-intervention rates due to smaller vessels and perceived narrower narrowing.
The new guidelines emphasize the importance of timely thrombolysis and PCI, with a focus on reducing delays in treatment. They also highlight the benefits of primary PCI over thrombolysis in certain situations.
The European Society of Cardiology has launched a new initiative called Women at Heart to improve the handling of women with cardiovascular disease. The initiative aims to highlight the growing burden and under-appreciation of women's heart disease, and promote better understanding and treatment among medical professionals.
A report by the British Cardiac Society highlights the challenges women face in pursuing careers in cardiology due to long hours, lack of flexible training, and sexism. The specialty is losing talented female applicants, with only 9% of those applying for specialist registrar posts being women.
A European Society of Cardiology consensus report recommends regular physical examination, detailed medical history investigation, and a 12-lead ECG for all young athletes involved in organized sport. This could potentially cut sports-related cardiac deaths by 50%-70% if implemented across Europe.
A study published in Pacing and Clinical Electrophysiology journal confirms catheter ablation is safe for patients, with no significant damage to cardiac nerves. The procedure is now a standard therapy for various arrhythmias, including SVT, atrial fibrillation, and AV nodal re-entrant tachycardia.
Researchers have found that fat buildup in the heart muscle, called lipotoxicity, is associated with metabolic irregularities and insulin resistance in obese and diabetic patients. Gene expression and protein findings provide potential long-term targets for treating heart failure, which affects 5 million US patients annually.
The trial found that early and aggressive statin use can reduce the long-term incidence of heart attacks, death from heart attack, stroke or readmission to the hospital for a cardiac event. However, benefits only became evident longer term, with no differences in endpoints during the first four months.
The European Society of Cardiology provides recommendations for athletes with cardiovascular disease, balancing risks and benefits of competitive sport. The panel aims to inform physicians and cardiologists about safe sport activities for candidates with cardiovascular abnormalities.
The Azithromycin and Coronary Events Study (ACES) found no reduction in cardiovascular events among participants treated with azithromycin. The study suggests that Chlamydia pneumoniae may not play a significant role in the late-stage development of coronary heart disease.
The study group report emphasizes the need for systematic screening by 12-lead ECG to identify hypertrophic cardiomyopathy and other lethal cardiovascular diseases. The consensus document advocates for a common European screening protocol based on 12-lead ECG to prevent sports-related sudden death.
The landmark PROVE IT-TIMI 22 trial found that a long-term regimen of antibiotics designed to kill Chlamydia pneumoniae does not reduce the risk of heart attacks or cardiovascular disease. Researchers recommend focusing on proven therapies like high-dose statin therapy and ACE inhibitors instead.
The final pooled analysis of SPORTIF III and V1,2 confirms ximelagatran's effectiveness in preventing strokes in patients with atrial fibrillation. Ximelagatran offers a safer alternative to warfarin without coagulation monitoring or dose titration, reducing the risk of stroke by 62%.
The ADONIS trial found that dronedarone significantly decreased the risk of a first recurrence of atrial fibrillation or flutter within the 12-month study period by 27.5% compared to placebo. The drug also displayed good cardiac tolerability with no cases of torsades de pointes.
The ACTION study found that adding nifedipine to existing treatments for stable angina reduces the need for hospital interventions by 13% and prevents heart attacks and strokes. Nifedipine also reduces hospitalizations for heart failure in patients with stable angina.
The EURIDIS trial demonstrated that dronedarone significantly lowers the risk of first recurrence of AF/AFL within the 12-month study period by 21.6% compared to placebo. Dronedarone proved effective for all recurrences of atrial fibrillation or flutter, including those that were symptomatic.
Patients with atrial fibrillation are at increased risk for stroke and clotting complications, yet a significant percentage do not receive recommended clot-preventing medications. Asymptomatic patients should instead receive simple rate controlling drugs like beta-blockers, digitalis or verapamil.
The European Society of Cardiology awarded Ireland's Minister for Health and Children the Gold Medal for his efforts to move cardiovascular disease up the political agenda. The Minister has led initiatives in public health and medical arenas, including heart health promotion and data registration standards.
The European Society of Cardiology is calling for consistency across Europe in terms of data collection and analysis in cardiology. The CARDS meeting aims to agree European data standards, enabling local, national and international comparisons of data using set standards.
The STARR program improves patient knowledge of exercise and diet goals by 56.7%, while also increasing exercise and diet compliance to 67%. The program shows positive trends in weight loss, stress, blood pressure, diabetes control, and lipid goals.
Researchers found that platelets in heart disease patients clot more easily despite taking aspirin, increasing the risk of heart attack. Further studies will investigate additional anti-clotting agents and genetic factors affecting platelet function.
Researchers have developed an antibody-coated stent that reduces restenosis and prevents blood clots, leading to improved cardiovascular treatment outcomes. The device captures endothelial progenitor cells to promote healing and prevent re-narrowing of the artery.
Researchers present findings on heart disease in women, including a study linking reduced kidney function to coronary artery disease. They also showcase an innovative new-generation stent that overcomes design limitations and allows for tailored drug delivery.
A new imaging technique combining transesophageal magnetic resonance (TE MRI) with standard cardiac MRI provides better views of plaque buildup in the aorta. The combined approach revealed more detailed images of plaque thickness, area, and volume than individual techniques, showing promise for improved diagnosis.
Dr. Shah will receive the ACC's Gifted Teacher Award for his teaching, and the Vulnerable Plaque Lifetime Achievement Award from AEHA for his pioneering research on preventing and reversing plaque buildup. These awards recognize his contributions to advancing cardiovascular care.
Researchers studied nondiabetic adults with a family history of diabetes and found they were 1.4 times more likely to develop coronary artery disease. Obese individuals were also at higher risk, defined by a body-mass index greater than 30, with a 2.2 times increased risk compared to normal weight individuals.
Research from the University of Michigan found that even with prenatal diagnosis, infants with one or more risk factors have a significantly lower chance of survival. However, in utero diagnosis has led to more pregnant women receiving specialty care, resulting in a higher-risk group of patients.
A study by Johns Hopkins Medicine found that consuming more saturated fats can lead to higher amounts of visceral fat, which is linked to a stronger risk factor for diabetes and cardiovascular diseases. A diet low in saturated fat and high in polyunsaturated fat, such as the Mediterranean diet, may help reduce visceral fat.
At the ACC's 52nd Annual Scientific Session, Emory Heart Center physicians will share information on the latest advances in cardiovascular medicine. Dr. Douglas Morris will present on new biological insights and approach to post-bypass patients, highlighting recent achievements in cardiac rehabilitation.
A new protein test has been developed to improve heart attack detection, particularly in cases of non-ST segment elevation heart attack. The test shows significant predictive value and could lead to a doubling of identified patients with mild heart attacks.
A multicenter study published in the American Journal of Cardiology found that adding Benecol spread to a patient's diet can lower LDL-C and total cholesterol levels by 17% and 12%, respectively. The study also showed that the cholesterol-lowering effect of Benecol was evident as early as the second week of treatment.
Researchers found that men with low HDL levels had nearly twice the mortality rate as those with higher levels after coronary bypass surgery. High HDL levels also helped clear bad cholesterol from the blood and protected against heart disease.
Research suggests that men with high HDL cholesterol levels after coronary bypass surgery live longer and experience fewer cardiac events. High levels of HDL cholesterol may be more significant than LDL in predicting long-term outcomes for patients undergoing heart surgery.
The new guidelines chart the rapid evolution of bypass surgery techniques and provide a framework for physicians to evaluate risks and benefits with their patients. The report categorizes heart patients into groups that predict how well bypass will work for them based on various factors.
A national study finds that doctors are increasingly prescribing ACE inhibitors to heart attack patients, but still underprescribing them to those most in need. The study suggests that following American College of Cardiology guidelines could have saved up to 1,800 lives in the first year.
A new study surveyed 26 men and 26 women with congestive heart failure, using standardized measurements to assess their quality of life. Women scored higher than men in physical functioning, bodily pain, general health, vitality, social functioning, mental health scores, depression, and feelings of peacefulness.
A new outcomes scorecard system developed by cardiologists at Duke University aims to improve the accuracy of comparing hospitals' performance in common cardiology procedures. The system analyzed data from almost 8,000 coronary disease patients and showed a wide variation in death rates among hospitals.